Approximately 33% of melanomas are derived directly from benign, melanocytic nevi.
Despite this, the vast majority of melanocytic nevi, which typically form as a result of BRAF …

Long-term utilization of immunosuppression in organ transplant recipients (OTRs) leads to
decreased immune-mediated tumor surveillance and development of malignant tumors. A …

Merkel cell carcinoma (MCC) is an aggressive cutaneous malignancy linked to a
contributory virus (Merkel cell polyomavirus). Multiple epidemiologic studies have …

Outcomes of kidney transplantation, in terms of graft and patient survival, have improved
over the past few decades, partly as a result of the introduction of new immunosuppressive …

The immunogenic characteristics of malignant melanoma are intriguing. To date, multiple
studies exist regarding the immunogenicity of melanoma. In this article, we summarize data …

Patients undergoing evaluation for solid organ transplantation (SOT) frequently have a
history of malignancy. Only patients with treated cancer are considered for SOT but the …

Skin cancer is a frequent complication of organ transplantation. Current guidelines advise
specialist skin surveillance but there are limited data on how these should be implemented …

Solid organ transplant recipients, who are medically immunosuppressed to prevent graft
rejection, have increased melanoma risk, but risk factors and outcomes are incompletely …

Importance Although it has been well established that patients with chronic lymphocytic
leukemia (CLL) have an increased risk of developing skin cancer, few studies have …

Purpose To delineate outcomes of malignant melanoma (MM) and Merkel cell carcinoma
(MCC) in patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma …